Please provide your email address to receive an email when new articles are posted on . In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association ...

(RTTNews) - CervoMed Inc. (CRVO) has announced positive 32-week data from the Extension phase of its phase IIb RewinD-LB trial of oral investigational drug Neflamapimod for the treatment of dementia ...

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and ...

New research suggests that two proteins, amyloid- and phosphorylated tau, the key proteins of Alzheimer's disease, are detected in blood once symptoms have started in Lewy's body diseases, such as ...

The U.S. Food and Drug Administration (FDA) will meet Cognition during a Type C meeting scheduled for the second half of January 2026. During the meeting, the next clinical studies for zervimesine in ...

Lewy body dementia is a progressive neurodegenerative disorder brought on by an excess of the protein alpha-synuclein in the brain. These deposits, known as Lewy bodies, can inhibit the production of ...

(WNDU) - We all know about Alzheimer’s disease, in fact, many of us know someone who has been impacted by it. But there is another form of dementia that affects more than a million Americans. And yet, ...

We all know about Alzheimer’s Disease, in fact, many of us know someone who has been impacted by it. But there is another form of dementia that affects more than a million Americans, and yet, few of ...

Lewy body dementia (LBD) is a type of progressive disease that has affected more than a million Americans, according to the Lewy Body Dementia Association. Over time, it destroys brain cells and can ...

What is Lewy body dementia? Dr. Frederich H. Lewy, a German neurologist working alongside Dr. Alois Alzheimer, first discovered the hallmark brain abnormalities in the 1900s. Alpha-synuclein protein, ...

Depression that appears later in life is often viewed as a response to declining health, but emerging evidence suggests it may sometimes signal deeper neurological changes.

Early detection of Alzheimer’s disease-related changes in Parkinson's disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated tau (p-tau) ...